» Authors » Cliff P Connery

Cliff P Connery

Explore the profile of Cliff P Connery including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 309
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Muslim Z, Stroever S, Poulikidis K, Connery C, Nitzkorski J, Bhora F
Asian Cardiovasc Thorac Ann . 2023 Nov; 32(1):19-26. PMID: 37994000
Background: We hypothesized that academic facilities and high-volume facilities would be independently associated with improved survival and a greater propensity for performing surgery in locally advanced esophageal cancer. Methods: We...
2.
Muslim Z, Razi S, Poulikidis K, Latif M, Weber J, Connery C, et al.
JTCVS Open . 2022 Sep; 11:272-285. PMID: 36172419
Objectives: Safety-net hospitals deliver a significant level of care to uninsured patients, Medicaid-enrolled patients, and other vulnerable patients. Little is known about the impact of safety-net hospital status on outcomes...
3.
Muslim Z, Stroever S, Razi S, Poulikidis K, Baig M, Connery C, et al.
Ann Thorac Surg . 2022 Jul; 115(1):192-199. PMID: 35780818
Background: Treatment delays in lung cancer care in the United States may be attributable to a diverse range of patient, provider, and institutional factors, the precise contributions of which remain...
4.
Muslim Z, Stroever S, Poulikidis K, Weber J, Connery C, Herrera L, et al.
Innovations (Phila) . 2022 May; 17(2):148-155. PMID: 35499922
: We aimed to identify predictors of conversion to thoracotomy and test the hypothesis that conversion is associated with inferior perioperative outcomes in non-small cell lung cancer (NSCLC). : We...
5.
Muslim Z, Stroever S, Baig M, Weber J, Connery C, Bhora F
Interact Cardiovasc Thorac Surg . 2022 Jan; 34(1):49-56. PMID: 34999793
Objectives: We aimed to identify patient- and facility-specific predictors of collective adherence to 4 recommended best treatment practices in operable IIIAN2 non-small-cell lung cancer (NSCLC) and test the hypothesis that...
6.
Muslim Z, Baig M, Weber J, Detterbeck F, Connery C, Spera J, et al.
Asian Cardiovasc Thorac Ann . 2021 May; 29(9):935-942. PMID: 33975467
Background: The aim of this study is to identify patients with thymoma who should receive post-operative radiotherapy. Methods: The Surveillance, Epidemiology, and End Results database was queried for stage IIB-IV...
7.
Baig M, Razi S, Muslim Z, Weber J, Connery C, Bhora F
Am Surg . 2021 Apr; 89(1):120-128. PMID: 33876966
Background: Current recommendations for segmentectomy for non-small cell lung cancer (NSCLC) include size ≤2 cm, margins ≥ 2 cm, and no nodal involvement. This study further stratifies the selection criteria...
8.
Muslim Z, Baig M, Weber J, Connery C, Bhora F
Ann Thorac Surg . 2021 Mar; 113(2):466-472. PMID: 33662314
Background: The association of hospital volume with outcomes has been assessed previously for patients with non-small cell lung cancer (NSCLC), but there are limited data on the cumulative effect of...
9.
Baig M, Razi S, Stroever S, Weber J, Connery C, Bhora F
Eur J Cardiothorac Surg . 2020 Dec; 59(5):1014-1020. PMID: 33332526
Objectives: The extent of surgical resection for early-stage second primary lung cancer (SPLC) in patients with a previous lobectomy is unclear. We sought to compare anatomic lung resections (lobectomy and...
10.
Baig M, Razi S, Weber J, Connery C, Bhora F
J Thorac Dis . 2020 Nov; 12(10):5925-5933. PMID: 33209425
Background: Current practice guidelines recommend the following criteria for segmentectomy for non-small cell lung cancer (NSCLC): size ≤2 cm, margins ≥2 cm and no lymph node involvement. We sought to...